Natus to Participate in Morgan Stanley Virtual 18th Annual Global Healthcare Conference
Natus Medical, a key player in medical device solutions for nervous and sensory disorders, announced a series of one-on-one meetings with institutional investors. Scheduled for September 14, 2020, during the Morgan Stanley Virtual 18th Annual Global Healthcare Conference, these meetings will be led by CEO Jonathan Kennedy and CFO Drew Davies. Investors interested in participating should reach out to a Morgan Stanley representative. Natus continues to focus on delivering innovative solutions for patients of all ages.
- None.
- None.
PLEASANTON, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonathan Kennedy, President and Chief Executive Officer and Drew Davies, Executive Vice President and Chief Financial Officer will be hosting one-on-one meetings with institutional investors at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference on Monday, September 14th. Investors interested in scheduling a meeting should contact a Morgan Stanley representative.
About Natus Medical Incorporated
Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Additional information about Natus Medical can be found at www.natus.com.
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com
FAQ
What is the date of the upcoming investor meetings for Natus Medical?
Who will represent Natus Medical at the Morgan Stanley conference?
How can investors schedule a meeting with Natus Medical?
What type of disorders does Natus Medical focus on?
What is the stock symbol for Natus Medical?
